DATATRAK partners with Clinverse to reduce complexity and costs linked with clinical trials

DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced its newest DATATRAK Connect™ Technology Partner, Clinverse, Inc. Clinverse architected the industry's first end-to-end technology solution that automates the financial lifecycle of global clinical trials.

By implementing ClinPay®, Clinverse's flagship product, sponsors and CROs reduce workload, time, and related costs. ClinPay provides complete real-time, role-based visibility into and control over the financial status of their clinical trials, including payments, invoicing, and cash management.

"Clinverse and DATATRAK share common goals, focused on reducing complexity and costs typically associated with clinical trials," said Tim Lyons, Senior Director, DATATRAK Clinical Consulting Services. "Working together, DATATRAK ONE® and ClinPay seamlessly integrate, automating payments based on real-time data. Streamlining the payment process delivers enhanced data quality, trial safety, and efficiency for our partners, leveraging the most efficient financial tool on the market."

"DATATRAK is an ideal partner for our solutions," said Jeff Rogers, Chief Commercial Officer of Clinverse. "The many benefits of ClinPay can be realized in a true real-time single database architecture, which DATATRAK delivers. Our expertise in global currencies and trials reduces complexity and enhances efficiencies for all trial phases."

To find out how DATATRAK can help reduce risk, improve data quality, and provide efficiency to your trial, visit us at www.datatrak.com. 

Join DATATRAK Thought Leaders:

  • Twitter
  • LinkedIn
  • SlideShare
  • The DATATRAK Blog

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough in immunology: AbMAP’s novel approach to antibody modeling